Listen Top Shows Blog

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

Update: 2011-09-27

Share

Description

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

Professor John Abraham (Sociology, Sussex), 'Key Challenges of Pharmaceutical Development, Regulation and Public Health'. Paper delivered at CRASSH workshop 'Healthy Futures: Medical Regulation and Human Agency' (22 January, 2010). Video includes discussant, Professor Deborah Ashby (Imperial College, London).

Comments

In Channel

The financial crisis: a failure of capitalism or government policy?

The financial crisis: a failure of capitalism or government policy?

2011-11-0304:35

José Scheinkman: Speculation and Bubbles

José Scheinkman: Speculation and Bubbles

2011-11-0354:10

Modelling Futures: Understanding Risk and Uncertainty (Seminar series trailer)

Modelling Futures: Understanding Risk and Uncertainty (Seminar series trailer)

2011-11-0301:29

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

2011-09-2701:02:46

Christl Donnelly: Collaborative Research on the Spread of 2009 H1N1 Pandemic Influenza

Christl Donnelly: Collaborative Research on the Spread of 2009 H1N1 Pandemic Influenza

2011-09-2730:02

David Coggon: Chemical and Physical Hazards in the Environment

David Coggon: Chemical and Physical Hazards in the Environment

2011-09-2625:51

John Edmunds (Discussant): Epidemics session, Healthy Futures workshop (January 2010)

John Edmunds (Discussant): Epidemics session, Healthy Futures workshop (January 2010)

2011-09-2620:00

Jonathan Wolff: When is Cost-Benefit Analysis Morally Acceptable in Health Decision Making?

Jonathan Wolff: When is Cost-Benefit Analysis Morally Acceptable in Health Decision Making?

2011-09-2632:08

Kari Auranen: How uncertain should I be?

Kari Auranen: How uncertain should I be?

2011-09-2632:32

Stephen John (Discussant): Policy session, Healthy Futures workshop (January 2010)

Stephen John (Discussant): Policy session, Healthy Futures workshop (January 2010)

2011-09-2614:38

Frank Fischer: The Risk Society

Frank Fischer: The Risk Society

2011-09-2654:02

Mike Hulme: Censuring Climate

Mike Hulme: Censuring Climate

2011-09-2629:57

David Nally: Risk and the Regulation of Scarcity

David Nally: Risk and the Regulation of Scarcity

2011-09-2630:02

Keith Richards: Creating and Managing 'the largest poisoning of a people in history'

Keith Richards: Creating and Managing 'the largest poisoning of a people in history'

2011-09-2620:48

David Polya: Human Health Risks Attributable to Groundwater Arsenic in Southern Asia

David Polya: Human Health Risks Attributable to Groundwater Arsenic in Southern Asia

2011-09-2625:51

Peter Atkins: Environmental Risk, Health and the Law

Peter Atkins: Environmental Risk, Health and the Law

2011-09-2622:42

Steve Rayner: Handbags and Goat Entrails

Steve Rayner: Handbags and Goat Entrails

2010-12-0738:51

Question Time: Challenging Models in the Face of Uncertainty

Question Time: Challenging Models in the Face of Uncertainty

2010-12-0701:06:30

Mike Hulme: How do Climate Models Gain and Exercise Authority?

Mike Hulme: How do Climate Models Gain and Exercise Authority?

2010-12-0753:00

Lord Krebs: Risk, Uncertainty and Regulation

Lord Krebs: Risk, Uncertainty and Regulation

2010-12-0749:14

00:00

00:00

x

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

John Abraham: Key Challenges of Pharmaceutical Development, Regulation and Public Health

Glenn Jobson